The Effects of Nebivolol on the NO-system in Patients With Essential Hypertension

NCT01679652 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Nebivolol
DRUG: placebo

Sponsor

Erling Bjerregaard Pedersen